Age, NYHA class, LVEF, renin–angiotensin system inhibitors, severe valvular heart disease, AF, β-blocker, chronic renal insufficiency, diabetes mellitus with target organ damage, anemia. This evidence concerns the gene REN and diabetes mellitus.